| ER stress and unfolded protein response in cancer cachexia A Roy, A Kumar Cancers 11 (12), 1929, 2019 | 41 | 2019 |
| The toll-like receptor/MyD88/XBP1 signaling axis mediates skeletal muscle wasting during cancer cachexia KR Bohnert, P Goli, A Roy, AK Sharma, G Xiong, YS Gallot, A Kumar Molecular and Cellular Biology 39 (15), e00184-19, 2019 | 32 | 2019 |
| Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of stemness A Roy, S Sarker, P Upadhyay, A Pal, A Adhikary, K Jana, M Ray Biochemical pharmacology 156, 322-339, 2018 | 22 | 2018 |
| Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species A Roy, M Ahir, S Bhattacharya, PK Parida, A Adhikary, K Jana, M Ray Molecular Carcinogenesis 56 (9), 2086-2103, 2017 | 20 | 2017 |
| Creatine supplementation with methylglyoxal: a potent therapy for cancer in experimental models A Pal, A Roy, M Ray Amino Acids 48, 2003-2013, 2016 | 18 | 2016 |
| Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect A Pal, D Talukdar, A Roy, S Ray, A Mallick, C Mandal, M Ray International Journal of Nanomedicine, 3499-3518, 2015 | 18 | 2015 |
| The IRE1/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism A Roy, MT da Silva, R Bhat, KR Bohnert, T Iwawaki, A Kumar Elife 10, e73215, 2021 | 14 | 2021 |
| TAK1 preserves skeletal muscle mass and mitochondrial function through redox homeostasis A Roy, AK Sharma, K Nellore, VA Narkar, A Kumar FASEB BioAdvances 2 (9), 538, 2020 | 12 | 2020 |
| Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy A Roy, A Kumar Nature Communications 13 (1), 2201, 2022 | 11 | 2022 |
| MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms A Parveen, KR Bohnert, MT da Silva, Y Wen, R Bhat, A Roy, A Kumar FASEB journal: official publication of the Federation of American Societies …, 2021 | 10 | 2021 |
| Innately expressed estrogen-related receptors in the skeletal muscle are indispensable for exercise fitness DH Sopariwala, AS Rios, G Pei, A Roy, MT da Silva, HTT Nguyen, ... FASEB journal: official publication of the Federation of American Societies …, 2023 | 6 | 2023 |
| Cancer Stem Cells, Wnt, Hedgehog and Notch Signaling, the role of dietary phytochemicals: New insights for cancer therapy A Roy, M Ray, K Jana Transl. Med 3, e125, 2013 | 5 | 2013 |
| Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy MT da Silva, AS Joshi, TE Koike, A Roy, K Mathukumalli, DH Sopariwala, ... FASEB journal: official publication of the Federation of American Societies …, 2022 | 4 | 2022 |
| Therapeutic targeting of PTEN in Duchenne muscular dystrophy A Parveen, Y Wen, A Roy, A Kumar Molecular Therapy 29 (1), 8-9, 2021 | 4 | 2021 |
| Fn14 promotes myoblast fusion during regenerative myogenesis MT da Silva, AS Joshi, MB Castillo, TE Koike, A Roy, PH Gunaratne, ... Life Science Alliance 6 (12), 2023 | 2 | 2023 |
| Temporal regulation of TAK1 to counteract muscular dystrophy A Roy, TE Koike, AS Joshi, MT da Silva, K Mathukumalli, M Wu, A Kumar bioRxiv, 2022.07. 22.501199, 2022 | 1 | 2022 |
| ER stress and ERO1: Potential therapeutic targets for inherited myopathies A Roy, AS Joshi, A Kumar Cell Reports Medicine 5 (3), 2024 | | 2024 |
| The IRE1α/XBP1/Myomaker axis drives myoblast fusion in adult skeletal muscle AS Joshi, MT Da Silva, A Roy, TE Koike, M Wu, MB Castillo, ... | | 2023 |
| Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model A Roy, TE Koike, AS Joshi, MT da Silva, K Mathukumalli, M Wu, A Kumar JCI insight 8 (10), 2023 | | 2023 |
| Emerging role of TAK1 in the regulation of skeletal muscle mass A Roy, VA Narkar, A Kumar BioEssays 45 (4), 2300003, 2023 | | 2023 |
